NMN can accelerate the glucose clearance rate induced by insulin, and the increase in the clearance rate is about 25%±7%.
After taking NMN for 12 weeks, the elderly showed a 4.2% improvement in left hand grip strength and a 6.2% improvement in gait speed, indicating that NMN can improve muscle strength and performance in middle-aged and elderly people.
Within 1-3 hours of taking NMN, the triglyceride content in the volunteers' blood decreased by 75%, which has a significant lipid-lowering effect.
Effects of NMN on BMD and bone structural properties of the femurs. (A) Representative three-dimensional reconstructed images derived by micro-CT. (B) NAD+ levels in femurs were measured. (C) Quantitative analysis of Trabecular volumetric BMD in 3 individual groups of rats. (D) Quantitative analysis of BVF in 3 individual groups of rats. (E) Quantitative analysis of trabecular number in 3 individual groups of rats. (F) Quantitative analysis of trabecular thickness in 3 individual groups of rats. (G) Quantitative analysis of trabecular separation in 3 individual groups of rats. Data were expressed as mean ± SEM (n = 10 per group). **P < .01 vs. the Control group, ⁎⁎⁎P < .001 vs. the Control group, #P < .05 vs. the AlCl3 group, ##P < .01 vs. the AlCl3 group.
NMN therapy for the suppression of cardiovascular diseases-mediated retinal ischemic dysfunction.
Picture: Nicotinamide mononucleotide (NMN) repletion improves mitochondrial function and prevents mesenchymal stem cell (MSC) replicative senescence.(left)The nicotinamide adenine dinucleotide (NAD+)/Sirt3 signaling pathway is up-regulated in late passage mesenchymal stem cells (LP MSCs) treated by exogenous nicotinamide mononucleotide (NMN). (right)